Effect | None |
Trial Design | Double blind |
Trial Length | 6+ Months |
Number of Subjects | 78 |
Sex | Both Genders |
Age Range | 65+ |
The scores on the rating scales associated with cognitive decline and dementia (Hasegawa and MMSE) were improved with phosphatidylserine supplementation in elderly persons over 6 months at 300mg; performance in rating scales associated with everyday cognition were not significantly affected.